Immunotherapy

Question 1

Nivolumab

Answer 1

PD-1/PD-L1 Inhibitor
- Targets Lung

• Prevents binding to PD-L1 or PD-L2 receptor
  –> Prevents Down regulation of T Cell

Question 2

Pembrolizumab

Answer 2

PD-1/PD-L1 Inhibitor
- Targets Lung

• Prevents binding to PD-L1 or PD-L2 receptor
  –> Prevents Down regulation of T Cell

Question 3

Atezolizumab

Answer 3

PD-1/PD-L1 Inhibitor
- Targets Lung

• Prevents binding to PD-L1 or PD-L2 receptor
  –> Prevents Down regulation of T Cell

Question 4

Durvalumab

Answer 4

PD-1/PD-L1 Inhibitor
- Targets Several

• Prevents binding to PD-L1 or PD-L2 receptor
  –> Prevents Down regulation of T Cell

Question 5

Ipilimumab

Answer 5

CTLA Inhibitor
- Target Several

• Prevents binding to B7 protein
  –> Prevents Down regulation of T Cell

Question 6

Neoantigen

Answer 6

Delivery Strategies
- DNA/mRNA
- SLPs
- Pulsed DCs
- Nanovaccines